158 related articles for article (PubMed ID: 30248545)
1. KIF26B promotes cell proliferation and migration through the FGF2/ERK signaling pathway in breast cancer.
Teng Y; Guo B; Mu X; Liu S
Biomed Pharmacother; 2018 Dec; 108():766-773. PubMed ID: 30248545
[TBL] [Abstract][Full Text] [Related]
2. AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling.
Li J; Guo Y; Duan L; Hu X; Zhang X; Hu J; Huang L; He R; Hu Z; Luo W; Tan T; Huang R; Liao D; Zhu YS; Luo DX
Oncotarget; 2017 May; 8(20):33694-33703. PubMed ID: 28402270
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of KIF26B, Cell Migration and Proliferation of Human Ovarian Cancer Cell Lines In Vitro, and Patient Outcomes from Human Bioinformatic Analysis.
Yang X; Zhang L; Xie L
Med Sci Monit; 2018 Jun; 24():3863-3872. PubMed ID: 29880787
[TBL] [Abstract][Full Text] [Related]
4. Kinesin 26B modulates M2 polarization of macrophage by activating cancer-associated fibroblasts to aggravate gastric cancer occurrence and metastasis.
Huang LM; Zhang MJ
World J Gastroenterol; 2024 May; 30(20):2689-2708. PubMed ID: 38855156
[TBL] [Abstract][Full Text] [Related]
5. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
[TBL] [Abstract][Full Text] [Related]
6. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
7. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways.
Yu ZY; Jiang XY; Zhao RR; Qin JJ; Luo CJ; Ren YX; Ren W; Ma ZJ; Jiao ZY
Chin Med J (Engl); 2020 Apr; 133(8):919-928. PubMed ID: 32187050
[TBL] [Abstract][Full Text] [Related]
8. Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer.
Wang J; Cui F; Wang X; Xue Y; Chen J; Yu Y; Lu H; Zhang M; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Feb; 34(1):13. PubMed ID: 25652119
[TBL] [Abstract][Full Text] [Related]
9. HOTAIR may regulate proliferation, apoptosis, migration and invasion of MCF-7 cells through regulating the P53/Akt/JNK signaling pathway.
Yu Y; Lv F; Liang D; Yang Q; Zhang B; Lin H; Wang X; Qian G; Xu J; You W
Biomed Pharmacother; 2017 Jun; 90():555-561. PubMed ID: 28407576
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of TBC1 Domain Family Member 24 (BC1D24) Inhibits Breast Carcinoma Growth via IGF1R/PI3K/AKT Pathway.
Qu X; Zhao B; Hu M; Ji Z; Xu J; Xia W; Qu Y
Med Sci Monit; 2018 Jun; 24():3987-3996. PubMed ID: 29893377
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion.
Gu S; Liang H; Qi D; Mao L; Mao G; Qian L; Zhang S
Onco Targets Ther; 2018; 11():3195-3203. PubMed ID: 29881293
[TBL] [Abstract][Full Text] [Related]
12. ELK1-induced up-regulation of KIF26B promotes cell cycle progression in breast cancer.
Wang S; Zhang H; Liu H; Guo X; Ma R; Zhu W; Gao P
Med Oncol; 2021 Nov; 39(1):15. PubMed ID: 34817735
[TBL] [Abstract][Full Text] [Related]
13. Suppression of motor protein KIF3C expression inhibits tumor growth and metastasis in breast cancer by inhibiting TGF-β signaling.
Wang C; Wang C; Wei Z; Li Y; Wang W; Li X; Zhao J; Zhou X; Qu X; Xiang F
Cancer Lett; 2015 Nov; 368(1):105-114. PubMed ID: 26272184
[TBL] [Abstract][Full Text] [Related]
14. Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2.
Tu M; Lu C; Lv N; Wei J; Lu Z; Xi C; Chen J; Guo F; Jiang K; Li Q; Wu J; Song G; Wang S; Gao W; Miao Y
Cancer Lett; 2016 Dec; 383(2):272-281. PubMed ID: 27702660
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
17. KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer.
Zhou J; Chen WR; Yang LC; Wang J; Sun JY; Zhang WW; He ZY; Wu SG
Cancer Res Treat; 2019 Jul; 51(3):1207-1221. PubMed ID: 30590004
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 promotes proliferation, migration, and invasion of breast cancer cell line MCF-7 by upregulating DNA polymerase delta1 (POLD1).
Xu Y; Qin Q; Chen R; Wei C; Mo Q
Biochem Biophys Res Commun; 2018 Jul; 502(3):351-357. PubMed ID: 29807012
[TBL] [Abstract][Full Text] [Related]
19. Discrete functional and mechanistic roles of chromodomain Y-like 2 (CDYL2) transcript variants in breast cancer growth and metastasis.
Yang LF; Yang F; Zhang FL; Xie YF; Hu ZX; Huang SL; Shao ZM; Li DQ
Theranostics; 2020; 10(12):5242-5258. PubMed ID: 32373210
[No Abstract] [Full Text] [Related]
20. KIF26B, a novel oncogene, promotes proliferation and metastasis by activating the VEGF pathway in gastric cancer.
Zhang H; Ma RR; Wang XJ; Su ZX; Chen X; Shi DB; Guo XY; Liu HT; Gao P
Oncogene; 2017 Oct; 36(40):5609-5619. PubMed ID: 28581513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
